Recurrence of H Pylori : Incidence and Influential Factors in Sohag Government.
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 100
- 试验地点
- 2
- 主要终点
- recurrence of H. Pylori infection in patients who recieved medical treatment
研究概览
简要总结
This study aims to determine recurrence rates, identify influential factors, investigate key factors that contribute to recurrence, evaluate treatment effectiveness and to assess the efficacy of different eradication regimens and their role in reducing recurrence.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Screening
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age: 18-75 years old.
- •H. pylori infection: Confirmed by endoscopy, biopsy, or non-invasive tests (e.g., urea breath test, stool antigen test).
- •Symptoms: Presence of dyspepsia, peptic ulcer disease, or other H. pylori-related symptoms.
- •Laboratory tests: Normal liver and kidney function, and no significant abnormalities in blood counts.
排除标准
- •Patients receiving eradication therapy in the past taking proton pump inhibitors,, H2 blockers ,,bismuth ,, antibiotics or other medications that interfere with the result of the examination in the recent 4 weeks.
- •Gastrointestinal disorders: Severe gastrointestinal disorders (e.g., gastric cancer, inflammatory bowel disease ,gastric or duodenal ulcer with current or recent bleeding , or clinical significant gastrointestinal bleeding within 4 weeks of randomization).
- •Malignancies: Active or recent malignancies.
- •Severe comorbidities: Unstable or severe comorbidities (e.g., heart failure, liver cirrhosis).
研究组 & 干预措施
follow up of patients that had H. Pylori infection and recieved medical treatment for recurrence
follow up of patients that had H. Pylori infection and recieved medical treatment for recurrence and influential factors for recurrence
干预措施: follow up of patients that had H. Pylori infection and recieved medical treatment for recurrence (Behavioral)
结局指标
主要结局
recurrence of H. Pylori infection in patients who recieved medical treatment
时间窗: 4 weeks after successful medical treatment
H. Pylori antigen in stool
次要结局
未报告次要终点
研究者
Tomas Wagih Thabet
Resident, Internal Medicine Department, Faculty of Medicine, Sohag University
Sohag University